Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease

NCT05122598 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment
Early Alzheimer's Disease
Memory Impairment

Interventions

DRUG: COT
DRUG: Sham

Sponsor

Evon Medics LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]